Pathways of cancer cell evolution

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Genetics
  • Cancer and Oncology
  • Pediatrics
  • Biomedical Laboratory Science/Technology


  • Pathology, Paediatrics, Childhood cancer



We make genetic and functional maps of cancer cell evolution in patients by analyzing multiple tumour samples from the same patient. In particular, we aim to: 1. Make phylogenetic maps of cancer cell variation over anatomic space and treatment time in order to understand the conditions leading to treatment resistance; 2. Assess the functional effect on the RNA and protein levels of genetic variation in tumours; 3. Analyze to what extent clinical biomarkers exhibit variability within a tumour lineage – a potentially important source of error in clinical decision making; 4. Evaluate the potential of using parameters of genetic variation as biomarkers for response to treatment. To reach these aims we use a combination of traditional histopathology and next-generation sequencing technologies. We focus on three of the most common solid tumours in children: neuroblastoma, Wilms tumour and rhabdomyosarcoma.

Recent research outputs

Lily Deland, Simon Keane, Thomas Olsson Bontell, Helene Sjögren, Henrik Fagman, Ingrid Øra, Esther De La Cuesta, Magnus Tisell, Jonas A Nilsson, Katarina Ejeskär, Magnus Sabel & Frida Abel, 2021, In: Cancer Biology & Therapy. 22, 3, p. 184-195

Research output: Contribution to journalArticle

View All (48)